The granuloma in tuberculosis: Dynamics of a host-pathogen collusion

Frontiers in Immunology

Volumn 3, Issue JAN, 2012, Pages

  Ehlers, Stefan ^a,b   Schaible, Ulrich E ^a,c  

^a RESEARCH CENTER BORSTEL   (Germany)

^b UNIVERSITY OF KIEL   (Germany)

^c LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

Evolution; Granuloma; Immunopathology; Life cycle stages; Pulmonary; Tuberculosis

Indexed keywords

EID: 84874284985     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2012.00411     Document Type: Review

References (107)

1. Aagaard, C. S., Hoang, T., Dietrich, J., Cardona, P. J., Izzo, A., Dolganov, G., et al. (2011). A multistage tuberculosis vaccine that confers efficient protection before and after exposure. Nat. Med. 17, 189-195.
2. Aagaard, C. S., Hoang, T., Vingsbo-Lundberg, C., Dietrich, J., and Andersen, P. (2009). Quality and vaccine efficacy of CD4+ T cell responses directed to dominant and subdominant epitopes in ESAT-6 from Mycobacterium tuberculosis. J. Immunol. 183,2659-2668.
3. Aaron, L., Saadoun, D., Calatroni, I., Launay, O., Memain, N., Vincent, V., et al. (2004). Tuberculosis in HIV-infected patients: a comprehensive review. Clin. Microbiol. Infect. 10, 388-398.
4. Aly, S., Mages, J., Reiling, N., Kalinke, U., Decker, T., Lang, R., et al. (2009). Mycobacteria-induced gran-uloma necrosis depends on IRF-1. J. Cell Mol Med. 13, 2069-2082.
5. Andreu, N., Zelmer, A., Fletcher, T., Elk-ington, P. T., Ward, T. H., Ripoll, J., et al. (2010). Optimisation of bio-luminescent reporters for use with mycobacteria. PLoS ONE 5:e10777. doi:10.1371/journal.pone.0010777
6. Barry, C. E. III, Boshoff, H. I., Dar-tois, V., Dick, T., Ehrt, S., Flynn, J., et al. (2009). The spectrum of latent tuberculosis: rethinking the biology and intervention strategies. Nat. Rev. Microbiol. 7, 845-855.
7. Bartek, I. L., Rutherford, R., Gruppo, V., Morton, R. A., Morris, R. P., Klein, M. R., et al. (2009). The DosR reg-ulon of M. tuberculosis and antibacterial tolerance. Tuberculosis (Edinb.) 89,310-316.
8. Behar, S. M., Divangahi, M., and Remold, H. G. (2010). Evasion of innate immunity by Mycobacterium tuberculosis: is death an exit strategy? Nat. Rev. Microbiol. 8, 668-674.
9. Behler, F. F., Steinwede, K. F., Balboa, L. F., Ueberberg, B. F., Maus, R. F., Kirchhof, G. F., et al. (2012). Role of Mincle in alveolar macrophage-dependent innate immunity against mycobacterial infections in mice. J. Immunol. 189,3121-3129.
10. Berry, M. P., Graham, C. M., McNab, E W., Xu, Z., Bloch, S. A., Oni, T., et al. (2010). An interferon-inducible neutrophil-driven blood transcrip-tional signature in human tuberculosis. Nature 466, 973-977.
11. Boshoff, H. I., and Barry, C. E. III. (2005). Tuberculosis-metabolism and respiration in the absence of growth. Nat. Rev. Microbiol. 3, 70-80.
12. Capuano, S. V. III, Croix, D. A., Pawar, S., Zinovik, A., Myers, A., Lin, P. L., et al. (2003). Experimental Mycobacterium tuberculosis infection of cynomolgus macaques closely resembles the various manifestations of human M. tuberculosis infection. Infect. Immun. 71, 5831-5844.
13. Cardona, P. J. (2009). A dynamic reinfection hypothesis of latent tuberculosis infection. Infection 37, 80-86.
14. Cardona, P. J., and Ruiz-Manzano, J. (2004). On the nature of Mycobacterium tuberculosis -latent bacilli. Eur. Respir. J. 24,1044-1051.
15. Carroll, P., Schreuder, L. J., Muwanguzi-Karugaba, J., Wiles, S., Robertson, B.D., Ripoll, J., et al. (2010). Sensitive detection of gene expres sion in mycobacteria under replicating and non-replicating conditions using optimized far-red reporters. PLoS ONE 5:e9823. doi:10.1371/journal.pone.0009823
16. Chaisson, R. E., Schecter, G. F., Theuer, C.P., Rutherford, G. W., Echen-berg, D. F., and Hopewell, P. C. (1987). Tuberculosis in patients with the acquired immunodeficiency syn drome. Clinical features, response to therapy, and survival. Am. Rev. Respir. Dis. 136,570-574.
17. Churchyard, G. J., Kaplan, G., Fallows, D., Wallis, R. S., Onyebujoh, P., and Rook, G. A. (2009). Advances in immunotherapy for tuberculosis treatment. Clin. Chest Med. 30, 769-782, ix.
18. Comas, I., Chakravartti, J., Small, P. M., Galagan, J., Niemann, S., Kremer, K., et al. (2010). Human T cell epitopes of Mycobacterium tuberculosis are evolutionarily hyperconserved. Nat. Genet. 42,498-503.
19. Cooper, A. M. (2009). T cells in mycobacterial infection and disease. Curr. Opin. Immunol. 21, 378-384.
20. Cooper, A. M., Pearl, J. E., Brooks, J. V., Ehlers, S., and Orme, I. M. (2000). Expression of the nitric oxide syn-thase 2 gene is not essential for early control of Mycobacterium tuberculosis in the murine lung. Infect. Immun. 68, 6879-6882.
21. Corleis, B. F., Korbel, D. F., Wilson, R. F., Bylund, J. F., Chee, R. F., and Schaible, U. E. (2012). Escape of Mycobacterium tuberculosis from oxidative killing by neutrophils. Cell. Microbiol. 14, 1109-1121.
22. Court, N. F., Vasseur, V., Vasseur, V. F., Vacher, R. F., Fremond, C. F., She-bzukhov, Y. F., et al. (2010). Partial redundancy of the pattern recognition receptors, scavenger receptors, and C-type lectins for the long-term control of Mycobacterium tuberculosis infection. J. Immunol. 184, 7057-7070.
23. Dannenberg, A. M. Jr. (1991). Delayed-type hypersensitivity and cell-mediated immunity in the pathogenesis of tuberculosis. Immunol. Today 12, 228-233.
24. Dannenberg, A.M. Jr., and Collins, E M. (2001). Progressive pulmonary tuberculosis is not due to increasing numbers of viable bacilli in rabbits, mice and guinea pigs, but is due to a continuous host response to mycobacterial products. Tuberculosis (Edinb.) 81,229-242.
25. Dannenberg, A. M. Jr., and Rook, G. A. W (1994). "Pathogenesis of pulmonary tuberculosis: an interplay of tissue-damaging and macrophage-activating immune response -dual mechanisms that control bacil-lary multiplication," in Tuberculosis: Pathogenesis, Protection, and Control ed. B. R. Bloom (Washington, DC: American Society for Microbiology Press), 459-483.
26. Dannenberg, A. M. Jr., and Sugimoto, M. (1976). Liquefaction of caseous foci in tuberculosis. Am. Rev. Respir. Dis. 113,257-259.
27. D'Avila, H., Melo, R. C., Parreira, G. G., Werneck-Barroso, E., Castro-Faria-Neto, H. C., and Bozza, P. T. (2006). Mycobacterium bovis bacillus Calmette-Guerin induces TLR2-mediated formation of lipid bodies: intracellular domains for eicosanoid synthesis in vivo. J. Immunol. 176, 3087-3097.
28. Davis, J. M., and Ramakrishnan, L. (2009). The role of the granuloma in expansion and dissemination of early tuberculous infection. Cell 136, 37-49.
29. Demissie, A., Leyten, E. M., Abebe, M., Wassie, L., Aseffa, A., Abate, G., et al. (2006). Recognition of stage-specific mycobacterial antigens differentiates between acute and latent infections with Mycobacterium tuberculosis. Clin. Vaccine Immunol. 13, 179-186.
30. Diel, R., Loddenkemper, R., Meywald-Walter, K., Niemann, S., and Nien-haus, A. (2008). Predictive value of a whole blood IFN-gamma assay for the development of active tuberculosis disease after recent infection with Mycobacterium tuberculosis. Am. J. Respir. Crit. Care Med. 177, 1164-1170.
31. Divangahi, M., Chen, M., Gan, H., Desjardins, D., Hickman, T. T., Lee, D. M., et al. (2009). Mycobacterium tuberculosis evades macrophage defenses by inhibiting plasma membrane repair. Nat. Immunol. 10,899-906.
32. Egen, J. G., Rothfuchs, A. G., Feng, C. G., Horwitz, M. A., Sher, A., and Germain, R. N. (2011). Intravital imaging reveals limited antigen presentation and T cell effector function in mycobacterial granulomas. Immunity 34, 807-819.
33. Egen, J. G., Rothfuchs, A. G., Feng, C. G., Winter, N. F., Sher, A. F., and Germain, R. N. (2008). Macrophage and T cell dynamics during the development and disintegration of mycobacterial granulomas. Immunity 28, 271-284.
34. Ehlers, S. (2010). TB or not TB? Fishing for molecules making permissive granulomas. Cell Host Microbe 7, 6-8.
35. Ehlers, S., Benini, J., Held, H. D., Roeck, C., Alber, G., and Uhlig, S. (2001). Alphabeta T cell receptor-positive cells and interferon-gamma, but not inducible nitric oxide syn-thase, are critical for granuloma necrosis in a mouse model of mycobacteria-induced pulmonary immunopathology. J. Exp. Med. 194, 1847-1859.
36. Eum, S. Y., Kong, J. H., Hong, M. S., Lee, Y. J., Kim, J. H., Hwang, S. H., et al. (2010). Neutrophils are the predominant infected phagocytic cells in the airways of patients with active pulmonary TB. Chest 137, 122-128.
37. Feng, C. G., Kaviratne, M., Rothfuchs, A. G., Cheever, A., Hieny, S., Young, H. A., et al. (2006). NK cell-derived IFN-gamma differentially regulates innate resistance and neutrophil response in T cell-deficient hosts infected with Mycobacterium tuberculosis. J. Immunol. 177, 7086-7093.
38. Fennelly, K. P., Martyny, J. W., Fulton, K. E., Orme, I. M., Cave, D. M., and Heifets, L. B. (2004). Cough-generated aerosols of Mycobacterium tuberculosis: a new method to study infectiousness. Am. J. Respir. Crit. Care Med. 169,604-609.
39. Fischer, K. F., Chatterjee, D. F., Tor-relles, J. F., Brennan, P. J., Kauf-mann, S. H., and Schaible, U. E. (2001). Mycobacterial lysocar-diolipin is exported from phago-somes upon cleavage of cardiolipin by a macrophage-derived lysosomal phospholipase A2. J. Immunol. 167, 2187-2192.
40. Flynn, J. L., Goldstein, M. M., Chan, J., Triebold, K. J., Pfeffer, K., Lowen-stein, C. J., et al. (1995). Tumor necrosis factor-alpha is required in the protective immune response against Mycobacterium tuberculosis in mice. Immunity 2, 561-572.
41. Gandotra, S., Jang, S., Murray, P. J., Salgame, P., and Ehrt, S. (2007). Nucleotide-bindingoligomerization domain protein 2-deficient mice control infection with Mycobacterium tuberculosis. Infect. Immun. 75,5127-5134.
42. Garton, N. J., Waddell, S. J., Sherratt, A. L., Lee, S. M., Smith, R. J., Sen-ner, C., et al. (2008). Cytological and transcript analyses reveal fat and lazy persister-like bacilli in tuberculous sputum. PLoS Med. 5:e75. doi:10.1371/journal.pmed.0050075
43. Geisel, R. E., Sakamoto, K. F., Russell, D. G., and Rhoades, E. R. (2005). In vivo activity of released cell wall lipids of Mycobacterium bovis bacillus Calmette-Guerin is due principally to tre-halose mycolates. J. Immunol. 174, 5007-5015.
44. Golchin, S. A., Stratford, J., Curry, R. J., and McFadden, J. (2012). A microfluidic system for long-term time-lapse microscopy studies of mycobacteria. Tuberculosis (Edinb.) 92,489-496.
45. Gordon, S., and Martinez, F. O. (2010). Alternative activation of macrophages: mechanism and functions. Immunity 32, 593-604.
46. Gould, T. A., van de Langemheen, H., Munoz-Elias, E. J., McKinney, J. D., and Sacchettini, J. C. (2006). Dual role of isocitrate lyase 1 in the glyoxylate and methylcitrate cycles in Mycobacterium tuberculosis. Mol. Microbiol. 61, 940-947.
47. Griffin, J. E., Pandey, A. K., Gilmore, S. A., Mizrahi, V., McKinney, J. D., Bertozzi, C. R., et al. (2012). Cholesterol catabolism by Mycobacterium tuberculosis requires transcriptional and metabolic adaptations. Chem. Biol. 19,218-227.
48. Hänsch, H. C., Smith, D. A., Mielke, M. E., Hahn, H., Bancroft, G. J., and Ehlers, S. (1996). Mechanisms of granuloma formation in murine Mycobacterium avium infection: the contribution of CD4+ T cells. Int. Immunol. 8, 1299-1310.
49. Heitmann, L., Schoenen, H., Ehlers, S., Lang, R., and Hölscher, C. (2012). Mincle is not essential for controlling Mycobacterium tuberculosis infection. Immunobiology. PMID: 22784441. [Epub ahead of print].
50. Hernandez-Pando, R., Jeyanathan, M., Mengistu, G., Aguilar, D., Orozco, H., Harboe, M., et al. (2000). Persistence of DNA from Mycobacterium tuberculosis in superficially normal lung tissue during latent infection. Lancet 356,2133-2138.
51. Hunter, R. L., Jagannath, C., and Actor, J. K. (2007). Pathology of postprimary tuberculosis in humans and mice: contradiction of long-held beliefs. Tuberculosis (Edinb.) 87, 267-278.
52. Hunter, R. L., Olsen, M. R., Jagannath, C., and Actor, J. K. (2006). Multiple roles of cord factor in the pathogen-esis of primary, secondary, and cavi-tary tuberculosis, including a revised description of the pathology of secondary disease. Ann. Clin. Lab Sci. 36, 371-386.
53. Ishikawa, E., Ishikawa, T., Morita, Y. S., Toyonaga, K., Yamada, H., Takeuchi, O., et al. (2009). Direct recognition of the mycobacterial glycolipid, tre-halose dimycolate, by C-type lectin Mincle. J. Exp. Med. 206,2879-2888.
54. Kana, B. D., Gordhan, B. G., Downing, K. J., Sung, N., Vostroktunova, G., Machowski, E. E., et al. (2008). The resuscitation-promoting factors of Mycobacterium tuberculosis are required for virulence and resuscitation from dormancy but are collectively dispensable for growth in vitro. Mol. Microbiol. 67, 672-684.
55. Keller, C., Hoffmann, R., Lang, R., Brandau, S., Hermann, C., and Ehlers, S. (2006). Genetically determined susceptibility to tuberculosis in mice causally involves accelerated and enhanced recruitment of granulocytes. Infect. Immun. 74, 4295-4309.
56. Kim, M. J., Wainwright, H. C., Lock-etz, M., Bekker, L. G., Walther, G. B., Dittrich, C., et al. (2010). Caseation of human tuberculosis granulomas correlates with elevated host lipid metabolism. EMBO Mol. Med. 2, 258-274.
57. Kong, Y., Yao, H., Ren, H., Subbian, S., Cirillo, S. L., Sacchettini, J. C., et al. (2010). Imaging tuberculosis with endogenous beta-lactamase reporter enzyme fluorescence in live mice. Proc. Natl. Acad. Sci. U.S.A. 107, 12239-12244.
58. Korbel, D. S., Schneider, B. E., and Schaible, U. E. (2008). Innate immunity in tuberculosis: myths and truth. Microbes Infect. 10, 995-1004.
59. Kramnik, I. (2008). Genetic dissection of host resistance to Mycobacterium tuberculosis: the sst1 locus and the Ipr1 gene. Curr. Top. Microbiol. Immunol. 321,123-148.
60. Lawn, S. D., Butera, S. T., and Shinnick, T. M. (2002). Tuberculosis unleashed: the impact of human immunodeficiency virus infection on the host granulomatous response to Mycobacterium tuberculosis. Microbes Infect. 4, 635-646.
61. Lee, W.B., Kang, J.S., Yan, J.J., Lee, M.S., Jeon, B. Y., Cho, S. N., et al. (2012). Neutrophils promote mycobacterial trehalose dimycolate-induced lung inflammation via the Mincle pathway. PLoS Pathog. 8:e1002614. doi:10.1371/journal.ppat. 1002614
62. Leistikow, R. L., Morton, R. A., Bartek, I. L., Frimpong, I., Wagner, K., and Voskuil, M. I. (2010). The Mycobacterium tuberculosis DosR regulon assists in metabolic homeostasis and enables rapid recovery from non-respiring dormancy.J. Bacteriol. 192, 1662-1670.
63. Lenaerts, A. J., Hoff, D., Aly, S., Ehlers, S., Andries, K., Cantarero, L., et al. (2007). Location of persisting mycobacteria in a Guinea pig model of tuberculosis revealed by r207910. Antimicrob. Agents Chemother. 51, 3338-3345.
64. Lin, P. L., and Flynn, J. L. (2010). Understanding latent tuberculosis: a moving target. J. Immunol. 185, 15-22.
65. Lin, P. L., Rodgers, M., Smith, L., Big-bee, M., Myers, A., Bigbee, C., et al. (2009). Quantitative comparison of active and latent tuberculosis in the cynomolgus macaque model. Infect. Immun. 77, 4631-4642.
66. Lockhart, E., Green, A. M., and Flynn, J. L. (2006). IL-17 production is dominated by gammadelta T cells rather than CD4 T cells during Mycobacterium tuberculosis infection. J. Immunol. 177, 4662-4669.
67. Mack, U., Migliori, G. B., Sester, M., Rieder, H. L., Ehlers, S., Goletti, D., et al. (2009). LTBI: latent tuberculosis infection or lasting immune responses to M. tuberculosis? A TBNET consensus statement. Eur. Respir. J. 33, 956-973.
68. Maertzdorf, J. F., Weiner, J. III, Mol-lenkopf, H. J., Bauer, T., Prasse, A., Muller-Quernheim, J., et al. (2012). Common patterns and disease-related signatures in tuberculosis andsarcoidosis. Proc. Natl. Acad. Sci. U.S.A 109, 7853-7858.
69. Manca, C., Tsenova, L., Bergtold, A., Freeman, S., Tovey, M., Musser, J. M., et al. (2001). Virulence of a Mycobacterium tuberculosis clinical isolate in mice is determined by failure to induce Th1 type immunity and is associated with induction of IFN-alpha/beta. Proc. Natl. Acad. Sci. U.S.A. 98, 5752-5757.
70. Marrero, J., Rhee, K. Y., Schnappinger, D., Pethe, K., and Ehrt, S. (2010). Gluconeogenic carbon flow of tri-carboxylic acid cycle intermediates is critical for Mycobacterium tuberculosis to establish and maintain infection. Proc. Natl. Acad. Sci. U.S.A. 107, 9819-9824.
71. Mattow, J., Siejak, F., Hagens, K., Becher, D., Albrecht, D., Krah, A. et al. (2006). Proteins unique to intraphagosomally grown Mycobac-terium tuberculosis. Proteomics 6, 2485-2494.
72. McKinney, J. D., Honer zu, B. K., Munoz-Elias, E. J., Miczak, A., Chen, B., Chan, W. T., et al. (2000). Persistence of Mycobacterium tuberculosis in macrophages and mice requires the glyoxylate shunt enzyme isoci-trate lyase. Nature 406, 735-738.
73. Meintjes, G., Rabie, H., Wilkinson, R. J., and Cotton, M. E (2009). Tuberculosis-associated immune reconstitution inflammatory syndrome and unmasking of tuberculosis by antiretroviral therapy. Clin. Chest Med. 30, 797-810.
74. Mueller, A. K., Behrends, J., Hagens, K., Mahlo, J., Schaible, U. E., and Schneider, B. E. (2012). Natural transmission of Plas-modium berghei exacerbates chronic tuberculosis in an experimental co-infection model. PLoS ONE 7:e48110. doi:10.1371/journal.pone.0048110
75. Munoz-Elias, E. J., Upton, A. M., Cher-ian, J., and McKinney, J. D. (2006). Role of the methylcitrate cycle in Mycobacterium tuberculosis metabolism, intracellular growth, and virulence. Mol. Microbiol. 60,1109-1122.
76. Neyrolles, O., Hernandez-Pando, R., Pietri-Rouxel, F., Fornes, P., Tailleux, L., Barrios Payan, J. A., et al. (2006). Is adipose tissue a place for Mycobacterium tuberculosis persistence? PLoS ONE 1:e43. doi:10.1371/journal.pone.0000043
77. North, R. J., and Izzo, A. A. (1993). Granuloma formation in severe combined immunodeficient (SCID) mice in response to progressive BCG infection. Tendency not to form granulomas in the lung is associated with faster bacterial growth in this organ. Am.J. Pathol. 142,1959-1966.
78. North, R. J., and Jung, Y. J. (2004). Immunity to tuberculosis. Annu. Rev. Immunol. 22, 599-623.
79. Orme, I. M., and Collins, E M. (1983). Protection against Mycobacterium tuberculosis infection by adoptive immunotherapy. Requirement for T cell-deficient recipients. J. Exp. Med. 158, 74-83.
80. Pandey, A. K., and Sassetti, C. M. (2008). Mycobacterial persistence requires the utilization of host cholesterol. Proc. Natl. Acad. Sci. U.S.A. 105, 4376-4380.
81. Parks, Q. M., Young, R. L., Poch, K. R., Malcolm, K. C., Vasil, M. L., and Nick, J. A. (2009). Neutrophil enhancement of Pseudomonas aeruginosa biofilm development: human F-actin and DNA as targets for therapy. J. Med. Microbiol. 58, 492-502.
82. Peyron, P., Vaubourgeix, J., Poquet, Y., Levillain, F., Botanch, C., Bardou, F., et al. (2008). Foamy macrophages from tuberculous patients' granulomas constitute a nutrient-rich reservoir for M. tuberculosis persistence. PLoS Pathog. 4:e1000204. doi:10.1371/journal.ppat.1000204
83. Raghuvanshi, S. F., Sharma, P., Singh, S., Van Kaer, L., and Das, G. (2010). Mycobacterium tuberculosis evades host immunity by recruiting mes-enchymal stem cells. Proc. Natl. Acad. Sci. U.S.A. 107,21653-21658.
84. Ramakrishnan, L. (2012). Revisiting the role of the granuloma in tuberculosis. Nat. Rev. Immunol. 12, 352-366.
85. Reece, S. T., Loddenkemper, C., Askew, D. J., Zedler, U., Schommer-Leitner, S., Stein, M., et al. (2010). Serine protease activity contributes to control of Mycobacterium tuberculosis in hypoxic lung granulomas in mice. J. Clin. Invest. 120, 3365-3376.
86. Reiling, N., Ehlers, S., and Holscher, C. (2007). MyDths and un-TOLLed truths: sensor, instructive and effector immunity to tuberculosis. Immunol. Lett. 116, 15-23.
87. Rook, G. A. (2007). Th2 cytokines in susceptibility to tuberculosis. Curr. Mol. Med. 7, 327-337.
88. Rook, G. A., Dheda, K., and Zumla, A. (2005). Immune responses to tuberculosis in developing countries: implications for new vaccines. Nat. Rev. Immunol. 5, 661-667.
89. Rook, G. A., Hernandez-Pando, R., and Zumla, A. (2009). Tuberculosis due to high-dose challenge in partially immune individuals: a problem for vaccination? J. Infect. Dis. 199,613-618.
90. Ruggiero, A., Tizzano, B., Pedone, E., Pedone, C., Wilmanns, M., and Beri-sio, R. (2009). Crystal structure of the resuscitation-promoting factor (DeltaDUF)RpfB from M. tuberculosis. J. Mol. Biol. 385, 153-162.
91. Russell, D. G. (2007). Who puts the tubercle in tuberculosis? Nat. Rev. Microbiol. 5, 39-47.
92. Russell, D. G., Barry, C. E. III. and Flynn, J. L. (2010). Tuberculosis: what we don't know can, and does, hurt us. Science 328, 852-856.
93. Russell, D. G., Cardona, P. J., Kim, M. J., Allain, S., and Altare, E (2009). Foamy macrophages and the progression of the human tuberculosis granuloma. Nat. Immunol. 10, 943-948.
94. Ryan, G. J., Hoff, D. R., Driver, E. R., Voskuil, M. I., Gonzalez-Juarrero, M., Basaraba, R. J., et al. (2010). Multiple M. tuberculosis phenotypes in mouse and guinea pig lung tissue revealed by a dual-staining approach. PLoS ONE 5:e11108. doi:10.1371/journal.pone.0011108
95. Sanghi, S., Grewal, R. S., Vasudevan, B., and Lodha, N. (2011). Immune reconstitution inflammatory syndrome in leprosy. Indian J. Lepr. 83, 61-70.
96. Schoenen, H., Bodendorfer, B., Hitchens, K., Manzanero, S., Wern-inghaus, K., Nimmerjahn, F., et al. (2010). Cutting edge: mincle is essential for recognition and adjuvanticity of the mycobacterial cord factor and its synthetic analog trehalose-dibehenate. J. Immunol. 184,2756-2760.
97. Smith, D., Hansch, H., Bancroft, G., and Ehlers, S. (1997). T-cell-independent granuloma formation in response to Mycobacterium avium: role of tumour necrosis factor-alpha and interferon-gamma. Immunology 92,413-421.
98. Subbian, S., Tsenova, L., O'Brien, P., Yang, G., Koo, M. S., Peixoto, B., et al. (2011). Phosphodiesterase-4 inhibition alters gene expression and improves isoniazid-mediated clearance of Mycobacterium tuberculosis in rabbit lungs. PLoS Pathog. 7:e1002262. doi:10.1371/journal.ppat.1002262
99. Talaat, A. M., Ward, S. K., Wu, C. W., Rondon, E., Tavano, C., Bannantine, J. P., et al. (2007). Mycobacterial bacilli are metabolically active during chronic tuberculosis in murine lungs: insights from genome-wide transcriptional profiling. J. Bacteriol. 189,4265-4274.
100. Timm, J., Post, E A., Bekker, L. G., Walther, G. B., Wainwright, H. C., Manganelli, R., et al. (2003). Differential expression of iron-, carbon-, and oxygen-responsive mycobacterial genes in the lungs of chronically infected mice and tuberculosis patients. Proc. Natl. Acad. Sci. U.S.A. 100,14321-14326.
101. Turner, O. C., Basaraba, R. J., and Orme, I. M. (2003). Immunopatho-genesis of pulmonary granulomas in the guinea pig after infection with Mycobacterium tuberculosis. Infect. Immun. 71, 864-871.
102. Ulrichs, T.,andKaufmann, S. H. (2006). New insights into the function of granulomas in human tuberculosis. J. Pathol. 208,261-269.
103. Vilcheze, C., and Jacobs, W R. Jr. (2007). The mechanism of isoniazid killing: clarity through the scope of genetics. Annu. Rev. Microbiol. 61, 35-50.
104. Volkman, H. E., Pozos, T. C., Zheng, J., Davis, J. M., Rawls, J. F., and Ramakrishnan, L. (2010). Tuberculous granuloma induction via interaction of a bacterial secreted protein with host epithelium. Science 327, 466-469.
105. Voskuil, M. I., Visconti, K. C., and Schoolnik, G. K. (2004). Mycobacterium tuberculosis gene expression during adaptation to stationary phase and low-oxygen dormancy. Tuberculosis (Edinb.) 84,218-227.
106. Walter, K., Holscher, C., Tschopp, J., and Ehlers, S. (2010). NALP3 is not necessary for early protection against experimental tuberculosis. Immuno-biology 215, 804-811.
107. Zelmer, A., Carroll, P. F., Andreu, N. F., Hagens, K. F., Mahlo, J. E, Redinger, N. F., et al. (2012). A new in vivo model to test anti-tuberculosis drugs using fluorescence imaging. J. Antimicrob. Chemother. 67, 1948-1960.